Overview
Cancer Treatment and Research Communications, published by Elsevier BV (United States), published 757 papers in 2021–2025, and its papers received 6,343 citations in those years. Its h-index is 38 and its two-year mean citedness is 1.28. On the ITS Journal Score it ranks #11,104 of 62,158 ranked journals and #2,654 of 8,757 in Medicine.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 134 | 2,016 | 134 |
| 2021 | 197 | 2,989 | 197 |
| 2022 | 167 | 1,853 | 167 |
| 2023 | 102 | 751 | 102 |
| 2024 | 81 | 499 | 81 |
| 2025 | 210 | 251 | 210 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Clinical Lung Cancer | Medicine | 73.3 | 849 | 41% |
| Translational Lung Cancer Research | Medicine | 73.3 | 1,620 | 100% |
| Lung Cancer Targets and Therapy | Medicine | 58.0 | 70 | 100% |
| Journal of Thoracic Oncology | Medicine | 74.8 | 10,750 | 61% |
| JTO Clinical and Research Reports | Medicine | 64.1 | 679 | 100% |
| Lung Cancer | Medicine | 74.7 | 3,096 | 25% |
| Thoracic Cancer | Medicine | 72.6 | 2,099 | 100% |
| Precision Cancer Medicine | Medicine | 54.8 | 128 | 82% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 2468-2942
- Print ISSN: 2468-2942
- Publisher: Elsevier BV
- Listed in DOAJ: Yes (checked against DOAJ)
- Crossref: ISSN found in Crossref
- OpenAlex: S4210186504
- Journal website: www.journals.elsevier.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Cancer Treatment and Research Communications?
It is 62.9 out of 100, which places it #11,104 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Cancer Treatment and Research Communications?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 1.28.
Is Cancer Treatment and Research Communications open access?
100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.
Does Cancer Treatment and Research Communications charge a publication fee?
DOAJ records an article processing charge of US$2,940. Check the journal's website for the current fee and any waivers.